 E28 |
 |
Ovarian dysfunction  |
| |
| Excludes1 |
isolated gonadotropin deficiency (E23.0)
postprocedural ovarian failure (E89.4-)
|
|
| |
 E28.0 |
|
Estrogen excess |
| |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
| sex |
Female
|
|
|
| |
| E28.1 |
|
Androgen excess |
| |
| Hypersecretion of ovarian androgens |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
| sex |
Female
|
|
|
| |
| E28.2 |
|
Polycystic ovarian syndrome |
| |
| Sclerocystic ovary syndrome | | Stein-Leventhal syndrome |
| sex |
Female
|
|
|
| |
| E28.3 |
|
Primary ovarian failure |
| |
| Excludes1 |
pure gonadal dysgenesis (Q99.1)
Turner's syndrome (Q96.-)
|
|
| |
| E28.31 |
|
Premature menopause |
| |
| E28.310 |
|
Symptomatic premature menopause |
| |
| Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with premature menopause |
| sex |
Female
|
| age |
Adult: [15-124]
|
|
| | |
| E28.319 |
|
Asymptomatic premature menopause |
| |
| Premature menopause NOS |
| sex |
Female
|
| age |
Adult: [15-124]
|
|
| | | |
| E28.39 |
|
Other primary ovarian failure |
| |
| Decreased estrogen | | Resistant ovary syndrome |
| sex |
Female
|
|
| |
| |
| E28.8 |
|
Other ovarian dysfunction |
| |
| Ovarian hyperfunction NOS |
| Excludes1 |
postprocedural ovarian failure (E89.4-)
|
| sex |
Female
|
|
|
| |
| E28.9 |
|
Ovarian dysfunction, unspecified |
| |
|
|